These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 15853831

  • 1. Evaluation of GH reserve in patients with adrenal incidentalomas and biochemical evidence of subclinical autonomous glucocorticoid hypersecretion.
    Tzanela M, Zianni D, Stylianidou Ch, Karavitaki N, Tsagarakis S, Thalassinos NC.
    Clin Endocrinol (Oxf); 2005 May; 62(5):597-602. PubMed ID: 15853831
    [Abstract] [Full Text] [Related]

  • 2. GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism.
    Procopio M, Maccario M, Savio P, Valetto MR, Aimaretti G, Grottoli S, Oleandri SE, Baffoni C, Tassone F, Arvat E, Camanni F, Ghigo E.
    Minerva Endocrinol; 1999 May; 24(3-4):107-11. PubMed ID: 10953725
    [Abstract] [Full Text] [Related]

  • 3. GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism.
    Procopio M, Maccario M, Savio P, Valetto MR, Aimaretti G, Grottoli S, Oleandri SE, Baffoni C, Tassone F, Arvat E, Camanni F, Ghigo E.
    Panminerva Med; 1998 Mar; 40(1):13-7. PubMed ID: 9573747
    [Abstract] [Full Text] [Related]

  • 4. Assessment of GH reserve before and after successful treatment of adult patients with Cushing's syndrome.
    Tzanela M, Karavitaki N, Stylianidou C, Tsagarakis S, Thalassinos NC.
    Clin Endocrinol (Oxf); 2004 Mar; 60(3):309-14. PubMed ID: 15008995
    [Abstract] [Full Text] [Related]

  • 5. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.
    Tsagarakis S, Kokkoris P, Roboti C, Malagari C, Kaskarelis J, Vlassopoulou V, Alevizaki C, Thalassinos N.
    Clin Endocrinol (Oxf); 1998 May; 48(5):627-33. PubMed ID: 9666875
    [Abstract] [Full Text] [Related]

  • 6. Effect of arginine and pyridostigmine on the GHRH-induced GH rise in obesity and Cushing's syndrome.
    Procopio M, Invitti C, Maccario M, Grottoli S, Cavagnini F, Camanni F, Ghigo E.
    Int J Obes Relat Metab Disord; 1995 Feb; 19(2):108-12. PubMed ID: 7735336
    [Abstract] [Full Text] [Related]

  • 7. Aberrant adrenal sensitivity to multiple ligands in unilateral incidentaloma with subclinical autonomous cortisol hypersecretion: a prospective clinical study.
    Reznik Y, Lefebvre H, Rohmer V, Charbonnel B, Tabarin A, Rodien P, Lecomte P, Bardet S, Coffin C, Mahoudeau J, REHOS study group.
    Clin Endocrinol (Oxf); 2004 Sep; 61(3):311-9. PubMed ID: 15355446
    [Abstract] [Full Text] [Related]

  • 8. Differences in reproducibility and peak growth hormone responses to repeated testing with various stimulators in healthy adults.
    Hoeck HC, Jakobsen PE, Vestergaard P, Falhof J, Laurberg P.
    Growth Horm IGF Res; 1999 Feb; 9(1):18-24. PubMed ID: 10207504
    [Abstract] [Full Text] [Related]

  • 9. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A, Murray RD, Teasdale GM, Shalet SM.
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [Abstract] [Full Text] [Related]

  • 10. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome.
    Castro M, Elias LL, Elias PC, Moreira AC.
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925
    [Abstract] [Full Text] [Related]

  • 11. Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients.
    Alvarez-Castro P, Isidro ML, Garcia-Buela J, Leal-Cerro A, Broglio F, Tassone F, Ghigo E, Dieguez C, Casanueva FF, Cordido F.
    Clin Endocrinol (Oxf); 2004 Aug; 61(2):250-5. PubMed ID: 15272922
    [Abstract] [Full Text] [Related]

  • 12. Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas.
    Tsagarakis S, Roboti C, Kokkoris P, Vasiliou V, Alevizaki C, Thalassinos N.
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):165-71. PubMed ID: 9828902
    [Abstract] [Full Text] [Related]

  • 13. Growth hormone secretion in primary adrenal Cushing's syndrome is disorderly and inversely correlated with body mass index.
    van Aken MO, Pereira AM, Frölich M, Romijn JA, Pijl H, Veldhuis JD, Roelfsema F.
    Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E63-70. PubMed ID: 15328071
    [Abstract] [Full Text] [Related]

  • 14. The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state.
    Broglio F, Gianotti L, Destefanis S, Fassino S, Abbate Daga G, Mondelli V, Lanfranco F, Gottero C, Gauna C, Hofland L, Van der Lely AJ, Ghigo E.
    Clin Endocrinol (Oxf); 2004 May; 60(5):592-9. PubMed ID: 15104562
    [Abstract] [Full Text] [Related]

  • 15. Impairment of GH responsiveness to combined GH-releasing hormone and arginine administration in adult patients with Prader-Willi syndrome.
    Grugni G, Marzullo P, Ragusa L, Sartorio A, Trifirò G, Liuzzi A, Crinò A, Genetic Obesity Study Group of the Italian Society of Pediatric Endocrinology and Diabetology.
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):492-9. PubMed ID: 16984242
    [Abstract] [Full Text] [Related]

  • 16. Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone.
    Terzolo M, Bossoni S, Alí A, Doga M, Reimondo G, Milani G, Peretti P, Manelli F, Angeli A, Giustina A.
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1310-5. PubMed ID: 10720081
    [Abstract] [Full Text] [Related]

  • 17. Hormonal activity of adrenal incidentalomas: results from a long-term follow-up study.
    Vassilatou E, Vryonidou A, Michalopoulou S, Manolis J, Caratzas J, Phenekos C, Tzavara I.
    Clin Endocrinol (Oxf); 2009 May; 70(5):674-9. PubMed ID: 19067718
    [Abstract] [Full Text] [Related]

  • 18. Plasma and salivary 6beta-hydroxycortisol measurements for assessing adrenocortical activity in patients with adrenocortical adenomas.
    Varga I, Jakab C, Szücs N, Patócs A, Tóth M, Kiss R, Gláz E, Rácz K.
    Horm Metab Res; 2003 Jul; 35(7):421-6. PubMed ID: 12931273
    [Abstract] [Full Text] [Related]

  • 19. Growth hormone releasing hormone plus arginine stimulation testing in young adults treated in childhood with cranio-spinal radiation therapy.
    Ham JN, Ginsberg JP, Hendell CD, Moshang T.
    Clin Endocrinol (Oxf); 2005 May; 62(5):628-32. PubMed ID: 15853837
    [Abstract] [Full Text] [Related]

  • 20. Growth hormone releasing hormone priming increases growth hormone secretion in patients with Cushing's syndrome.
    Leal-Cerro A, Pumar A, Villamil F, Astorga R, Dieguez C, Casanueva FF.
    Clin Endocrinol (Oxf); 1993 Apr; 38(4):399-403. PubMed ID: 8319372
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.